儿童颅内室管膜瘤的疗效评估:儿童神经肿瘤疗效评估(RAPNO)工作组的推荐
RAPNO工作组由国际儿童与成人神经肿瘤学家、神经放射学家、放射肿瘤学家和神经外科医生组成,针对儿童颅内室管膜瘤制定疗效评估推荐。推荐包括基于肿瘤体积变化评估疾病缓解、采用无事件生存作为临床试验终点,以及使用脑和脊柱MRI、脑脊液细胞学、神经系统检查和类固醇使用进行评估。术后24-48小时应获取基线术后影像以评估残留肿瘤,推荐和缓解定义应在前瞻性临床试验中验证。
要点
- 基于肿瘤体积变化评估疾病缓解。
- 无大块病灶患者进入临床试验时采用无事件生存作为研究终点。
- 术后24-48小时获取基线术后影像评估残留肿瘤。
核心结论
- RAPNO工作组针对儿童颅内室管膜瘤提出疗效评估推荐和缓解定义,并建议在前瞻性临床试验中验证。
研究设计与样本
- RAPNO工作组由国际儿童与成人神经肿瘤学家、神经放射学家、放射肿瘤学家和神经外科医生组成,设立分委员会制定儿童室管膜瘤疗效评估标准。
- 通过回顾当前实践和文献识别评估儿童室管膜瘤对临床试验治疗反应的主要挑战,数据稀缺或不可用领域通过迭代过程达成共识。
主要发现
- RAPNO疗效评估推荐包括基于肿瘤体积变化评估疾病缓解。
- 推荐对无大块病灶患者进入临床试验时使用无事件生存作为研究终点。
- 推荐评估内容包括脑和脊柱MRI、脑脊液细胞学、神经系统检查和类固醇使用。
- 术后24-48小时应获取基线术后影像以评估残留肿瘤。
关键数值与推荐
- 基于肿瘤体积变化评估疾病缓解。
- 无大块病灶患者进入临床试验时采用无事件生存作为研究终点。
- 使用脑和脊柱MRI、脑脊液细胞学、神经系统检查和类固醇使用进行疗效评估。
- 术后24-48小时获取基线术后影像评估残留肿瘤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Response criteria for paediatric intracranial ependymoma vary historically and across different international cooperative groups. The Response Assessment in the Pediatric Neuro-Oncology (RAPNO) working group, consisting of an international panel of paediatric and adult neuro-oncologists, neuro-radiologists, radiation oncologists, and neurosurgeons, was established to address both the issues and the unique challenges in assessing the response in children with CNS tumours. We established a subcommittee to develop response assessment criteria for paediatric ependymoma. Current practice and literature were reviewed to identify major challenges in assessing the response of paediatric ependymoma to clinical trial therapy. For areas in which data were scarce or unavailable, consensus was reached through an iterative process. RAPNO response assessment recommendations include assessing disease response on the basis of changes in tumour volume, and using event-free survival as a study endpoint for patients entering clinical trials without bulky disease. Our recommendations for response assessment include the use of brain and spine MRI, cerebral spinal fluid cytology, neurological examination, and steroid use. Baseline postoperative imaging to assess for residual tumour should be obtained 24-48 h after surgery. Our consensus recommendations and response definitions should be prospectively validated in clinical trials.
引用
- Lindsay HB, Massimino M, Avula S, et al. Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol. 2022. PMID: 35901835. doi:10.1016/S1470-2045(22)00222-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。